Related News
Diabetes study boosts drugs
Source: Agencies |
June 8, 2009, Monday
|
Print Edition
Print Edition
DIABETICS with stable heart disease do just as well taking drugs alone as getting quick angioplasty or bypass surgery to open blocked heart arteries, United States researchers said yesterday.
They said patients advised to have angioplasty and a heart stent to restore blood flow and ease chest pain could safely wait and give drugs a chance to work.
But those with more severe disease sent for more invasive heart bypass surgery might be able to avoid a future heart attack if they had the surgery right away.
The study also found no difference in heart risks between two strategies for treating type 2 diabetes - increasing the amount of insulin or lowering the body's resistance to its own insulin with drugs such as either metformin or GlaxoSmithKline's Avandia, also known as rosiglitazone, which had been thought to raise the risk of heart attacks.
"If you have diabetes and heart disease such that a bypass surgery is a recommended procedure, you should have that early rather than delaying it," said Dr Trevor Orchard of the University of Pittsburgh, whose study appears in the New England Journal of Medicine.
For GlaxoSmithKline, the study represents a positive sign that Avandia may be safer than earlier analyses had suggested.
But it may be another blow for stent makers such as Boston Scientific Corp and Johnson & Johnson, whose US sales plummeted after a similar study two years ago.
Stents are wire mesh tubes that prop open diseased arteries after they have been unclogged during angioplasty.
They said patients advised to have angioplasty and a heart stent to restore blood flow and ease chest pain could safely wait and give drugs a chance to work.
But those with more severe disease sent for more invasive heart bypass surgery might be able to avoid a future heart attack if they had the surgery right away.
The study also found no difference in heart risks between two strategies for treating type 2 diabetes - increasing the amount of insulin or lowering the body's resistance to its own insulin with drugs such as either metformin or GlaxoSmithKline's Avandia, also known as rosiglitazone, which had been thought to raise the risk of heart attacks.
"If you have diabetes and heart disease such that a bypass surgery is a recommended procedure, you should have that early rather than delaying it," said Dr Trevor Orchard of the University of Pittsburgh, whose study appears in the New England Journal of Medicine.
For GlaxoSmithKline, the study represents a positive sign that Avandia may be safer than earlier analyses had suggested.
But it may be another blow for stent makers such as Boston Scientific Corp and Johnson & Johnson, whose US sales plummeted after a similar study two years ago.
Stents are wire mesh tubes that prop open diseased arteries after they have been unclogged during angioplasty.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
